O’Neal acquires biopharmaceutical engineering firm DME Alliance

Photo Credit: Pixabay Creative Commons

O’Neal Inc., a Greenville-based engineering and construction company, has acquired DME Alliance, a biopharmaceutical engineering firm based in Pennsylvania.

With the acquisition, O’Neal will be able to expand its biopharmaceutical engineering capabilities and grow its presence in other core markets throughout the Northeast by “building upon DME’s ongoing success,” according to a news release. Financial details of the acquisition have not been disclosed.

“Over the last several years clients have been requesting that O’Neal expand their BioPharm services to address the resurging industry,” said Kevin Bean, president and CEO of O’Neal, in a statement. “We feel that DME’s team is a perfect fit to build upon. Both companies focus on complex projects in the $5 to $50 million range and that is where the need is. We are excited to have the expertise of David Marks along with his complete team on board as we move forward.”

DME Alliance, which was founded by Marks in 2001, provides engineering solutions for the biotechnology, pharmaceutical, medical device, science and technology, food and beverage, and chemical process industries. Marks will continue to lead the company’s office in Allentown, Pennsylvania.

“It was the right timing and the perfect fit,” Marks said. “O’Neal has a full bench of resources to help us grow and help us better serve our clients. I am thrilled to be a part of the O’Neal team, who has a long, trusted history in the industry.”

Founded in 1975, O’Neal has offices in Greenville and Atlanta with ongoing construction projects in more than 15 states. Past clients include the U.S. Food and Drug Administration, Milliken, BMW, Clemson University, Huntsman Corp., Coca-Cola, and Mitsubishi.

For more information, visit http://www.onealinc.com.


Related Articles